Excess uric acid induces gouty nephropathy through crystal formation: a review of recent insights

Y Mei, B Dong, Z Geng, L Xu - Frontiers in Endocrinology, 2022 - frontiersin.org
Uric acid (UA) is the final product of purine metabolism in the human body, and impaired
purine metabolism can increase the uric acid in serum, finally resulting in hyperuricemia …

Global trends in research of gouty arthritis over past decade: a bibliometric analysis

P Deng, S Wang, X Sun, Y Qi, Z Ma, X Pan… - Frontiers in …, 2022 - frontiersin.org
Gouty arthritis (GA), as a multifactorial disease, is characterised by intense pain, active
inflammation symptoms, and swollen joints. It has utterly complex pathogenesis, of which the …

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and …

GC Drosos, D Vedder, E Houben, L Boekel… - Annals of the …, 2022 - ard.bmj.com
Objective To develop recommendations for cardiovascular risk (CVR) management in gout,
vasculitis, systemic sclerosis (SSc), myositis, mixed connective tissue disease (MCTD) …

[HTML][HTML] Documento de información y consenso para la detección y manejo de la enfermedad renal crónica

R García-Maset, J Bover, JS de la Morena… - nefrologia, 2022 - Elsevier
La enfermedad renal crónica (ERC) es un importante problema de salud pública a nivel
mundial afectando a más del 10% de la población española. Se asocia a elevada …

Comparative effectiveness of allopurinol and febuxostat in gout management

JR O'Dell, MT Brophy, MH Pillinger, T Neogi… - NEJM …, 2022 - evidence.nejm.org
Background The relative efficacy and safety of allopurinol and febuxostat when used
according to current guidelines for the treatment of hyperuricemia are unknown. This double …

Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia

E Sands, A Kivitz, W DeHaan, SS Leung… - Nature …, 2022 - nature.com
Biologic drugs have transformed the standard of care for many diseases. However, many
biologics induce the formation of anti-drug antibodies (ADAs), which can compromise their …

The role of alcohol consumption in pathogenesis of gout

B Nieradko-Iwanicka - Critical reviews in food science and nutrition, 2022 - Taylor & Francis
Alcohol is recognized a risk factor for increased uric acid and gout flare. The aim of the study
was to review the literature in order to find out what is the role of alcohol consumption in …

Superiority of low‐dose benzbromarone to low‐dose febuxostat in a prospective, randomized comparative effectiveness trial in gout patients with renal uric acid …

F Yan, X Xue, J Lu, N Dalbeth, H Qi, Q Yu… - Arthritis & …, 2022 - Wiley Online Library
Objective The predominant mechanism driving hyperuricemia in gout is renal uric acid
underexcretion; however, the standard urate‐lowering therapy (ULT) recommendation is first …

Efficacy and safety of urate-lowering agents in asymptomatic hyperuricemia: systematic review and network meta-analysis of randomized controlled trials

T Sapankaew, K Thadanipon, N Ruenroengbun… - BMC nephrology, 2022 - Springer
Background Asymptomatic hyperuricemia was found to be associated with increased
cardiovascular disease risk but the potential benefits of urate-lowering therapy (ULT) remain …

Mapping knowledge structure and global research trends in gout: a bibliometric analysis from 2001 to 2021

P Wen, P Luo, B Zhang, Y Zhang - Frontiers in public health, 2022 - frontiersin.org
Background The incidence and prevalence of gout have been steadily increasing globally,
which has resulted in gout research attracting consistently increased attention. This study …